Eppendorf expands manufacturing in the U.S.
Since 1998, Eppendorf has manufactured bioreagents in Boulder, Colorado. The new plant on the East coast will allow for additional growth in the Life Sciences segment and reflects the importance and requirements of the U.S. market. The choice of Connecticut was supported by the existence of the so-called "plastic corridor" which provides excellent conditions for industrial manufacturing of high quality consumables.
"Enfield makes a perfect fit for Eppendorf, because our requirements were met to a high degree", Klaus Fink, CEO of Eppendorf AG, explains. "Strategically, our targets include vicinity to our markets, logistical advantages as well as reduced corporate exposure to currency exchange rates."
Most read news
Other news from the department manufacturing
Get the analytics and lab tech industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.